作者: Xuliang Lang , Lulu Li , Yuzong Chen , Qinsheng Sun , Qin Wu
DOI: 10.1016/J.BMC.2013.05.008
关键词:
摘要: Acridine derivatives have been explored as DNA-binding anticancer agents. Some show undesired pharmacokinetic properties and new need to be explored. In this work, a series of novel acridine analogues were synthesized by modifying previously unexplored linkers between the benzene groups their antiproliferative activity ability evaluated. Among these derivatives, compound 5c demonstrated capability topoisomerase I inhibitory activity. K562 cell lines, induced apoptosis through mitochondria-dependent intrinsic pathways. These data suggested that other with modified might potent